Skip to main navigation Skip to search Skip to main content

Cabozantinib versus everolimus in advanced renal-cell carcinoma

  • Toni K. Choueiri
  • , Bernard Escudier
  • , Thomas Powles
  • , Paul N. Mainwaring
  • , Brian I. Rini
  • , Frede Donskov
  • , Hans Hammers
  • , Thomas E. Hutson
  • , Jae Lyun Lee
  • , Katriina Peltola
  • , Bruce J. Roth
  • , Georg A. Bjarnason
  • , Lajos Geczi
  • , Bhumsuk Keam
  • , Pablo Maroto
  • , Daniel Y.C. Heng
  • , Manuela Schmidinger
  • , Philip W. Kantoff
  • , Anne Borgman-Hagey
  • , Colin Hessel
    • Christian Scheffold, Gisela M. Schwab, Nizar M. Tannir, Robert J. Motzer

Research output: Contribution to journal › Article › peer-review

1142   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Cabozantinib versus everolimus in advanced renal-cell carcinoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science